Skip to main content


Full Schedule

Full Schedule

  • Sunday, October 10, 2021
  • 8:30 AM – 9:45 AM EDT
    Independent Satellite Symposium: CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy
  • 10:00 AM – 10:45 AM EDT
    Biomarker Jeopardy
  • 10:00 AM – 6:15 PM EDT
    Industry Encore Posters
  • 11:00 AM – 11:45 AM EDT
    Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness - Pfizer Oncology
  • 12:00 PM – 12:45 PM EDT
    Updates in the Management of Renal Cell Carcinoma
  • 1:00 PM – 1:30 PM EDT
    Updates in Cholangiocarcinoma
  • 1:45 PM – 2:30 PM EDT
    Product Theater
  • 2:45 PM – 3:15 PM EDT
    The 4 T's of ITP: Tailoring Therapies to Treat Thrombocytopenia
  • 3:30 PM – 4:15 PM EDT
    Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO ® (nivolumab) - Exelixis
  • 4:30 PM – 5:15 PM EDT
    Biomarker Jeopardy
  • 5:30 PM – 6:15 PM EDT
    Updates in the Management of Renal Cell Carcinoma
  • 6:30 PM – 7:45 PM EDT
    Independent Satellite Symposium: CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy